Flecainide attenuates rate adaptation of ventricular repolarization in Guinea-pig heart

Scandinavian Cardiovascular Journal

Volumn 50, Issue 1, 2016, Pages 28-35

  Osadchii, Oleg E ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

Cardiac arrhythmia; flecainide; rate adaptation; ventricular repolarization

Indexed keywords

FLECAINIDE; ANTIARRHYTHMIC AGENT; SODIUM CHANNEL BLOCKING AGENT;

ACTION POTENTIAL; ACTION POTENTIAL DURATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; ENDOCARDIUM; EPICARDIUM; GUINEA PIG; HEART CYCLE; HEART PACING; HEART RATE; HEART REPOLARIZATION; HEART STIMULATION; HEART VENTRICLE EXTRASYSTOLE; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; REPOLARIZATION; VENTRICULAR REPOLARIZATION; ADAPTATION; ANIMAL; ARRHYTHMIAS, CARDIAC; DISEASE MODEL; DRUG EFFECTS; ELECTROCARDIOGRAPHY; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE; PATHOPHYSIOLOGY;

ACTION POTENTIALS; ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FLECAINIDE; GUINEA PIGS; HEART RATE; HEART VENTRICLES; MALE; SODIUM CHANNEL BLOCKERS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84983094810     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2015.1099721     Document Type: Article

References (25)

1. Locati EH, Maison-Blanche P, Dejode P, et al. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings. J Am Coll Cardiol. 1995; 25: 1564-1575.
2. Panidis IP, Morganroth J. Sudden death in hospitalized patients: Cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. J Am Coll Cardiol. 1983; 2: 798-805.
3. Denker S, Lehmann MH, Mahmud R, et al. Facilitation of macroreentry within the His-Purkinje system with abrupt changes in cycle length. Circulation. 1984; 69: 26-32.
4. Gill JS, Baszko A, Xia R, et al. Dynamics of the QT interval in patients with exercise-induced ventricular tachycardia in normal and abnormal hearts. Am Heart J. 1993; 126: 1357-1363.
5. Echt DS, Liebson PR, Mitchell B, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. New Engl J Med. 1991; 324: 781-788.
6. K, by flecainide and E-4031 in cat ventricular myocytes. Circulation. 1990; 82: 289-293.
7. + current of guinea-pig ventricular myocytes. J Mol Cell Cardiol. 1996; 28: 893-903.
8. Olsson SB, Edvardsson N. Clinical electrophysiologic study of antiarrhythmic properties of flecainide: Acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation. Am Heart J. 1981; 102: 864-871.
9. Lim KS, Jang IJ, Kim BH, et al. Changes in the QTc interval after administration of flecainide acetate, with and without co-administered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects. Clin Ther. 2010; 32: 659-666.
10. Hoffmann A, Wenk M, Follath F. Exercise-induced ventricular tachycardia as a manifestation of flecainide toxicity. Int J Cardiol. 1986; 11: 353-355.
11. Anastasiou-Nana MI, Anderson JL, Stewart JR, et al. Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: A probable proarrhythmic effect. Am Heart J. 1987; 113: 1071-1077.
12. Osadchii OE, Woodiwiss AJ, Norton GR. Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation. Pflugers Arch. 2006; 452: 155-163.
13. Osadchii OE, Olesen SP. Electrophysiological determinants of hypokalemia-induced arrhythmogenicity in the guinea-pig heart. Acta Physiol (Oxf). 2009; 197: 273-287.
14. Osadchii OE. Dofetilide promotes repolarization abnormalities in perfused guinea-pig heart. Cardiovasc Drugs Ther. 2012; 26: 489-500.
15. Conard GJ, Ober RE. Metabolism of flecainide. Am J Cardiol. 1984; 53: 41B-51.
16. Pueyo E, Husti Z, Hornyik T, et al. Mechanisms of ventricular rate adaptation as a predictor of arrhythmic risk. Am J Physiol Heart Circ Physiol. 2010; 298: H1577-H1587.
17. Viskin S, Postema PG, Bhuiyan ZA, et al. The response of the QT interval to the brief tachycardia provoked by standing: A bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 2010; 55: 1955-1961.
18. Eisner DA, Dibb KM, Trafford AW. The mechanism and significance of the slow changes of ventricular action potential duration following a change of heart rate. Exp Physiol. 2009; 94: 520-528.
19. Paul AA, Witchel HJ, Hancox JC. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. Br J Pharmacol. 2002; 136: 717-729.
20. Bentzen BH, Bahrke S, Wu K,. et al. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits. J Cardiovasc Pharmacol. 2011; 57: 223-230.
21. Coromilas J, Saltman AE, Waldecker B, et al. Electrophysiological effects of anisotropic conduction and reentry in infracted canine hearts. Circulation. 1995; 91: 2245-2263.
22. + channel distribution and electrophysiological heterogeneities in guinea-pig ventricular wall. Am J Physiol Heart Circ Physiol. 2011; 300: H989-1002.
23. Osadchii OE. Flecainide-induced proarrhythmia is attributed to abnormal changes in repolarization and refractoriness in perfused guinea-pig heart. J Cardiovasc Pharmacol. 2012; 60: 456-466.
24. Grom A, Faber TS, Brunner M, et al. Delayed adaptation of ventricular repolarization after sudden changes in heart rate due to conversion of atrial fibrillation. A potential risk factor for proarrhythmia? Europace. 2005; 7: 113-121.
25. Bueno-Orovio A, Hanson BM, Gill JS, et al. Slow adaptation of ventricular repolarization as a cause of arrhythmia? Methods Inf Med. 2014; 53: 320-323.